-
PJ Vaccines: A dynamic cohort study evaluating metabolic predictors of immune response to influenza vaccine in the elderly
Time of Update: 2023-01-04
DYNAMIC cohort study evaluating metabolic predictors of influenza vaccine immune response in older adults PJ Vaccines 2022 Nov 01; 7(1) Background: Prior to the pandemic and related non-pharmaceutical public health measures, influenza virus infection was a significant burden of morbidity, hospitalization, and death each year, especially among older adults.
-
2022 AGA Clinical Practice Guidelines Update: Endoscopic Treatment of Recurrent Acute Pancreatitis and Chronic Pancreatitis
Time of Update: 2022-10-20
Guide Q&A mini-sessionFrom now on, the clinical guideline APP will launch a guide Q&A activity every Tuesday, Thursday and Saturday!Participate in the Q&A activity to have a chance to get rewards~The event entrances are as follows:Endoscopy plays an indispensable role in the evaluation and management of patients with recurrent acute pancreatitis and chronic pancreatitis.
-
How does the laboratory traditional Chinese medicine grinder solve the difficulties of traditional Chinese medicine grinding
Time of Update: 2022-09-07
Among the many raw materials pulverized by laboratory pulverizers, traditional Chinese medicines also face many problems due to their complex nature .
Among the many raw materials pulverized by laboratory pulverizers, traditional Chinese medicines also face many problems due to their complex nature .
-
Neuron 'repair agent' may be 'part-time' to treat infertility
Time of Update: 2022-04-30
Studies have shown that in two animal models of premature ovarian failure, treatment with new antibody drugs can effectively maintain and promote follicle development, restore hormone homeostasis, and inhibit ovarian cell apoptosis .
-
JGH: Analysis of the efficacy of amitriptyline in the treatment of children with functional abdominal pain
Time of Update: 2021-12-24
However, recent studies have shown that it has a good effect on the treatment of functional abdominal pain in children (FAPD) .
Then compare the improvement of pain and quality of life (QOL) between the two groups of patients after receiving treatment .
-
Celiniso combined with Vd regimen can achieve excellent efficacy in all subgroups of R/R MM
Time of Update: 2021-12-05
Figure 1: Patients with different cytogenetic subgroups between the two treatment groups have high risk of PFS (78.
Patients in the standard-risk and high-risk groups who received XVd had a lower disease progression (PD) rate than those treated with Vd .
-
Phase 3 clinical results of C3 complement inhibitors for the treatment of age-related macular degeneration released
Time of Update: 2021-11-05
On September 9, Apellis announced the top-line results obtained in two phase 3 clinical trials, DERBY and OAKS, in the research pegcetacoplan targeting the complement C3 protein .
com/news-release/2021/09/09/2294782/0/en/Apellis-Announces-Top-Line-Results-from-Phase-3-DERBY-and-OAKS-Studies-in-Geographic-Atrophy-GA -and-Plans-to-Submit-NDA-to-FDA-in-the-First-Half-of-2022.
-
J Clin Oncol: Efficacy and safety of pembrolizumab + GVD (gemcitabine, vinorelbine and liposomal adriamycin) in the second-line treatment of relapsed or refractory classic Hodgkin's lymphoma
Time of Update: 2021-07-31
Therefore, a research team from the United States conducted a study to evaluate the efficacy of pembrolizumab combined with GVD (gemcitabine, vinorelbine, and liposomal adriamycin) in the second-line treatment of relapsed or refractory classic Hodgkin’s lymphoma And safety .
-
Neurology: Neurofeedback technology is conducive to the improvement of gait after stroke
Time of Update: 2021-05-21
The important significance of this study is that the use of fNIRS neurofeedback to promote SMA in motor imagination can enhance gait and balance recovery after stroke by adjusting SMA and its related networks.
-
How is Alzheimer's disease treated? Phase III trials of the AXS-05 are to be carried out
Time of Update: 2021-01-16
Alzheimer's disease is an aggressive neurodegenerative disease that is a common form of Alzheimer's disease characterized by cognitive decline and behavioral and psychological abnormalities, including restlessness.
-
Lancet Oxford Vaccine Phase III Clinical: Prevention of Symptomatic COVID-19 Effectiveness 70
Time of Update: 2021-01-01
This is the first complete Phase III trial results of oxford COVID-19 vaccine (AZD1222) for the Oxford vaccine. First, the safety of the vaccine was acceptable, with only 3 out of 23,745 participant
-
Professor Chen Mingyuan's team innovation: nasal endoscopy minimally invasive surgical technology to treat the initial treatment of early nasopharyngeal cancer
Time of Update: 2020-07-19
previous studies have shown that minimally invasive surgery has a significantly higher 5-year overall survival rate than intensity-modulated radiation therapy for locally recurrent nasopharyngeal carcinoma, with fewer treatment-related side effects and lower medical costs.
-
The efficacy of low-grade glioma chemotherapy was evaluated with 18F-FET-PET
Time of Update: 2020-06-03
In low-grade gliomas, the remission rate shown by imaging was relatively low, even if the patient's clinical performance or epilepsy improved Similar conditions exist in PATIENTS WITH WHO-III-GRADE GL
-
A new breakthrough! Olapari is FDA approved to treat metastatic anti-aggressive prostate cancer with HRR gene mutation
Time of Update: 2020-05-20
2020 May 20, AstraZeneca and Merck today announced that Li Puzhuo ® (English trade name: Lynparza, common name: Ola Palley) has been approved in the United States for treatment homologous recombina
-
Cornerstone pharmaceutical and Bayer have reached a global clinical cooperation to jointly evaluate the combination of PD-L1 McAb cs1001 and regofinib
Time of Update: 2019-06-10
Cornerstone Pharmaceutical (Suzhou) Co., Ltd announced today that it has reached a global clinical cooperation with Bayer health care LLC (hereinafter referred to as "Bayer") focusing on China The two
